Company intelligence / Profile preview
Sinoveda
Edmonton, Alberta, Canadasinoveda.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Sinoveda leverages its patented Pharmaceutical Platform Technology® to identify and standardize effective plant-based combination therapies. Its lead program for Long Covid demonstrated encouraging results in a small observational study and was approved as AntiCo in Hong Kong. The company’s pipeline includes both marketed products and preclinical candidates targeting oncology and metabolic diseases.
- Therapeutic areas
- OncologyCardiovascularInfectious Diseases
- Modalities
- Small molecules (plant-derived compounds)Combination therapies (botanical pharmaceuticals)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Sinoveda.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinoveda.